Results 141 to 150 of about 965,280 (210)
The risk of anemia and iron overload is a global concern in beta (β)-thalassemia. The β-thalassemia primary treatment includes blood transfusion and iron chelation therapy; however, both are associated with risks such as anemia, iron depletion,
Perpetua Modjadji +3 more
core +1 more source
Pharmacotherapy of Beta Thalassemia Major
The aim of this thesis is to discuss the incidence, aetiology, clinical manifestation, diagnosis and pharmacological management of beta thalassemia major.
Kazemi Mohammadi, Seyedeh Maral
core
α-Thalassemia among pediatric Nb S homozygotes
The number of α globin genes have been documented among 255 active SS patients under the age of 15 years. Ascertainment in the area served by our clinical program is 84%. The common -3.7 Kb α+ -Thalassemia (Th) had a gene frequency of 0.17. The incidence
McKie, Kathleen Mood +5 more
core
In Southeast Asia, where thalassemia is prevalent, heterozygous carriers of both β-thalassemia mutation and the (-(SEA)) α-globin gene deletion are encountered.
Ma, ESK +5 more
core
Successful gene therapy for transfusion-dependent α-thalassemia: a case report. [PDF]
Yin X +16 more
europepmc +1 more source
Planting seeds of cure before birth in α-thalassemia major. [PDF]
Rozmus J, Amid A.
europepmc +1 more source
Molecular Spectrum of α-Thalassemia Mutations in Antalya, Türkiye and Their Relationship with Hematological Parameters. [PDF]
Erkal Ö, Paksoy B.
europepmc +1 more source
Appropriate whole genome amplification and pathogenic loci detection can improve the accuracy of preimplantation genetic diagnosis for deletional α-thalassemia. [PDF]
Lan Y +10 more
europepmc +1 more source
Objectives: α-thalassemia is an autosomal recessive monogenic blood disorder, affecting up to 5% of the world's population. The occurrence rate of the disease in Vietnam varies up to up to 51.5%, with high rate of mutation carriers, of couples consisting
Phuong Le Thi +11 more
core +1 more source
In utero hematopoietic cell transplantation in fetuses with α-thalassemia major: a phase 1 clinical trial. [PDF]
MacKenzie TC +23 more
europepmc +1 more source

